Antibodies against chemokine receptors cxcr3 and cxcr4 predict progressive deterioration of lung function in patients with systemic sclerosis

HIGHLIGHTS

• who: Florian Weigold from the We analyzed , sera from , consecutive SSc patients from the Charité University Hospital for anti-, abs have published the research work: Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis, in the Journal: (JOURNAL)
• what: The authors did not investigate the predictive value of these antibodies on mortality, nor did the authors investigate the effects of disease-modifying agents on the results.

SUMMARY

And accumulation of T_cells, neutrophils, and monocytes in the inflammation sites. CXCR3, which can bind . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.